Published in J Invest Dermatol on March 11, 2010
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet (2012) 4.13
Activation of the aryl hydrocarbon receptor dampens the severity of inflammatory skin conditions. Immunity (2014) 2.02
IL-1F5, -F6, -F8, and -F9: a novel IL-1 family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expression. J Immunol (2011) 1.80
Deep sequencing of small RNAs from human skin reveals major alterations in the psoriasis miRNAome. Hum Mol Genet (2011) 1.74
A subset of methylated CpG sites differentiate psoriatic from normal skin. J Invest Dermatol (2011) 1.73
The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings. J Invest Dermatol (2012) 1.71
Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis. J Invest Dermatol (2012) 1.69
Interferon-γ decreases ceramides with long-chain fatty acids: possible involvement in atopic dermatitis and psoriasis. J Invest Dermatol (2013) 1.50
Increased expression of interleukin-17 pathway genes in nonlesional skin of moderate-to-severe psoriasis vulgaris. Br J Dermatol (2015) 1.47
IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis. J Allergy Clin Immunol (2012) 1.46
Psoriasis genetics: breaking the barrier. Trends Genet (2010) 1.38
Transcriptome analysis of psoriasis in a large case-control sample: RNA-seq provides insights into disease mechanisms. J Invest Dermatol (2014) 1.36
Dissecting the psoriasis transcriptome: inflammatory- and cytokine-driven gene expression in lesions from 163 patients. BMC Genomics (2013) 1.32
Combined use of laser capture microdissection and cDNA microarray analysis identifies locally expressed disease-related genes in focal regions of psoriasis vulgaris skin lesions. J Invest Dermatol (2012) 1.20
Interferon and biologic signatures in dermatomyositis skin: specificity and heterogeneity across diseases. PLoS One (2012) 1.11
Suppression of molecular inflammatory pathways by Toll-like receptor 7, 8, and 9 antagonists in a model of IL-23-induced skin inflammation. PLoS One (2013) 1.07
Analysis of long non-coding RNAs highlights tissue-specific expression patterns and epigenetic profiles in normal and psoriatic skin. Genome Biol (2015) 1.03
Heterogeneity of inflammatory and cytokine networks in chronic plaque psoriasis. PLoS One (2012) 1.00
Modulation of epidermal transcription circuits in psoriasis: new links between inflammation and hyperproliferation. PLoS One (2013) 0.99
Cytokines in psoriasis. Cytokine (2015) 0.98
Noncanonical microRNAs and endogenous siRNAs in normal and psoriatic human skin. Hum Mol Genet (2012) 0.93
Cross-study homogeneity of psoriasis gene expression in skin across a large expression range. PLoS One (2013) 0.88
Transcriptional landscape of psoriasis identifies the involvement of IL36 and IL36RN. BMC Genomics (2015) 0.88
Modulation of cardiometabolic pathways in skin and serum from patients with psoriasis. J Transl Med (2013) 0.88
Whole-exome SNP array identifies 15 new susceptibility loci for psoriasis. Nat Commun (2015) 0.88
A meta-analysis revealed insights into the sources, conservation and impact of microRNA 5'-isoforms in four model species. Nucleic Acids Res (2013) 0.87
Transcriptome classification reveals molecular subtypes in psoriasis. BMC Genomics (2012) 0.87
Proteomics of skin proteins in psoriasis: from discovery and verification in a mouse model to confirmation in humans. Mol Cell Proteomics (2014) 0.86
Alteration of the EphA2/Ephrin-A signaling axis in psoriatic epidermis. J Invest Dermatol (2012) 0.84
Genome-wide transcriptional analysis of T cell activation reveals differential gene expression associated with psoriasis. BMC Genomics (2013) 0.84
Susceptibility-associated genetic variation at IL12B enhances Th1 polarization in psoriasis. Hum Mol Genet (2013) 0.84
Biomarkers of An Autoimmune Skin Disease-Psoriasis. Genomics Proteomics Bioinformatics (2015) 0.82
TALE homeodomain proteins regulate site-specific terminal differentiation, LCE genes and epidermal barrier. J Cell Sci (2011) 0.82
MicroRNAs in normal and psoriatic skin. Physiol Genomics (2013) 0.82
NOD-like receptor signaling and inflammasome-related pathways are highlighted in psoriatic epidermis. Sci Rep (2016) 0.81
SKINOMICS: Transcriptional Profiling in Dermatology and Skin Biology. Curr Genomics (2012) 0.80
Selective programming of CCR10(+) innate lymphoid cells in skin-draining lymph nodes for cutaneous homeostatic regulation. Nat Immunol (2015) 0.79
Biologics for psoriasis: a translational research success story. J Invest Dermatol (2015) 0.79
The tryptophan metabolism enzyme L-kynureninase is a novel inflammatory factor in psoriasis and other inflammatory diseases. J Allergy Clin Immunol (2015) 0.79
Expression of human skin-specific genes defined by transcriptomics and antibody-based profiling. J Histochem Cytochem (2014) 0.79
Moving from capstones toward cornerstones: successes and challenges in applying systems biology to identify mechanisms of autism spectrum disorders. Front Genet (2015) 0.78
Psoriasis-Specific RNA Isoforms Identified by RNA-Seq Analysis of 173,446 Transcripts. Front Med (Lausanne) (2016) 0.77
Resveratrol ameliorates imiquimod-induced psoriasis-like skin inflammation in mice. PLoS One (2015) 0.76
Study on Certain Biomarkers of Inflammation in Psoriasis Through "OMICS" Platforms. Open Biochem J (2014) 0.76
Increased IL17A, IFNG, and FOXP3 Transcripts in Moderate-Severe Psoriasis: A Major Influence Exerted by IL17A in Disease Severity. Mediators Inflamm (2016) 0.75
MicroRNAs as regulatory elements in psoriasis. Open Med (Wars) (2016) 0.75
Computational Systems Biology of Psoriasis: Are We Ready for the Age of Omics and Systems Biomarkers? OMICS (2015) 0.75
IL-12 protects from psoriasiform skin inflammation. Nat Commun (2016) 0.75
Network analysis of psoriasis reveals biological pathways and roles for coding and long non-coding RNAs. BMC Genomics (2016) 0.75
Establishment and function of tissue-resident innate lymphoid cells in the skin. Protein Cell (2017) 0.75
Signs of innate immune activation and premature immunosenescence in psoriasis patients. Sci Rep (2017) 0.75
Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res (2003) 52.74
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature (2006) 46.36
Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol (2005) 30.22
Cellular responses to interferon-gamma. Annu Rev Immunol (1997) 13.23
Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol (2007) 12.76
Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet (2009) 9.45
Psoriasis is associated with increased beta-defensin genomic copy number. Nat Genet (2007) 8.07
Pathogenesis and therapy of psoriasis. Nature (2007) 6.94
Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat Genet (2009) 5.93
Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J (1991) 5.30
IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol (2006) 4.88
Etanercept as monotherapy in patients with psoriasis. N Engl J Med (2003) 4.57
Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. Am J Hum Genet (2006) 4.22
Epidermal barrier formation and recovery in skin disorders. J Clin Invest (2006) 4.14
Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J Exp Med (2005) 4.04
Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J Exp Med (2007) 3.68
Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21. Nat Genet (2009) 3.59
Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array. Physiol Genomics (2003) 3.39
A new secreted protein that binds to Wnt proteins and inhibits their activities. Nature (1999) 3.22
Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis. J Immunol (2008) 3.22
Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br J Dermatol (2008) 3.19
On the design and analysis of gene expression studies in human populations. Nat Genet (2007) 3.07
The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis. J Immunol (2007) 3.06
Overexpression of transforming growth factor alpha in psoriatic epidermis. Science (1989) 2.63
Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha. J Exp Med (2004) 2.63
S100 proteins in the epidermis. J Invest Dermatol (2004) 2.32
Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J Allergy Clin Immunol (2003) 2.21
Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. Hum Mol Genet (2001) 2.11
Type I interferon: potential therapeutic target for psoriasis? PLoS One (2008) 2.08
Global gene expression analysis reveals evidence for decreased lipid biosynthesis and increased innate immunity in uninvolved psoriatic skin. J Invest Dermatol (2009) 2.06
Two novel IL-1 family members, IL-1 delta and IL-1 epsilon, function as an antagonist and agonist of NF-kappa B activation through the orphan IL-1 receptor-related protein 2. J Immunol (2001) 2.03
Genomic analysis defines a cancer-specific gene expression signature for human squamous cell carcinoma and distinguishes malignant hyperproliferation from benign hyperplasia. J Invest Dermatol (2006) 2.01
Molecular cloning, occurrence, and expression of a novel partially secreted protein "psoriasin" that is highly up-regulated in psoriatic skin. J Invest Dermatol (1991) 1.99
Cyclosporine improves psoriasis in a double-blind study. JAMA (1986) 1.95
Candidate housekeeping genes require evaluation before their selection for studies of human epidermal keratinocytes. J Invest Dermatol (2008) 1.93
Psoriasis induced at the injection site of recombinant interferon gamma. Results of immunohistologic investigations. Arch Dermatol (1990) 1.80
High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis. J Invest Dermatol (2005) 1.78
Late cornified envelope family in differentiating epithelia--response to calcium and ultraviolet irradiation. J Invest Dermatol (2005) 1.78
Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation. J Clin Invest (2006) 1.65
Variants in the 5q31 cytokine gene cluster are associated with psoriasis. Genes Immun (2007) 1.59
Identification and gene organization of three novel members of the IL-1 family on human chromosome 2. Genomics (2000) 1.53
Increased expression of Wnt5a in psoriatic plaques. J Invest Dermatol (2006) 1.53
Effects of tumor necrosis factor-alpha (TNF alpha) in epidermal keratinocytes revealed using global transcriptional profiling. J Biol Chem (2004) 1.48
Transforming growth factor-beta 1 inhibits cytokine-mediated induction of human metalloelastase in macrophages. J Biol Chem (2000) 1.46
Antiproliferative effects of recombinant alpha- and gamma-interferons on cultured human keratinocytes. Lab Invest (1984) 1.38
Reddish, scaly, and itchy: how proteases and their inhibitors contribute to inflammatory skin diseases. Arch Immunol Ther Exp (Warsz) (2009) 1.36
Oncostatin M secreted by skin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammation. J Immunol (2007) 1.36
Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling. Pharmacogenomics J (2001) 1.34
Transcriptional responses of human epidermal keratinocytes to cytokine interleukin-1. J Cell Physiol (2008) 1.33
Molecular characterization and evolution of the SPRR family of keratinocyte differentiation markers encoding small proline-rich proteins. Genomics (1993) 1.30
SKALP/elafin is an inducible proteinase inhibitor in human epidermal keratinocytes. J Cell Sci (1994) 1.30
The psoriatic transcriptome closely resembles that induced by interleukin-1 in cultured keratinocytes: dominance of innate immune responses in psoriasis. Am J Pathol (2007) 1.29
Pathway-specific profiling identifies the NF-kappa B-dependent tumor necrosis factor alpha-regulated genes in epidermal keratinocytes. J Biol Chem (2005) 1.21
Potential role of the chemokine receptors CXCR3, CCR4, and the integrin alphaEbeta7 in the pathogenesis of psoriasis vulgaris. Lab Invest (2001) 1.18
Interferon in suction blister fluid from psoriatic lesions. Br J Dermatol (1983) 1.17
IFN-gamma activated indoleamine 2,3-dioxygenase activity in human cells is an antiparasitic and an antibacterial effector mechanism. Adv Exp Med Biol (1999) 1.17
Evidence for local control of gene expression in the epidermal differentiation complex. Exp Dermatol (2002) 1.15
Probing the S100 protein family through genomic and functional analysis. Genomics (2004) 1.15
"Spot 14" protein: a metabolic integrator in normal and neoplastic cells. Thyroid (1998) 1.14
Psoriasis genomics: analysis of proinflammatory (type 1) gene expression in large plaque (Western) and small plaque (Asian) psoriasis vulgaris. Br J Dermatol (2004) 1.11
Development and validation of human psoriatic skin equivalents. Am J Pathol (2008) 1.09
Interleukin-1alpha regulates antimicrobial peptide expression in human keratinocytes. Immunol Cell Biol (2007) 1.09
Infliximab monotherapy provides rapid and sustained benefit for plaque-type psoriasis. J Am Acad Dermatol (2003) 1.08
Interleukin-1: a key inflammatory mediator in psoriasis? Cytokine (2006) 1.06
IL-17 suppresses TNF-alpha-induced CCL27 production through induction of COX-2 in human keratinocytes. J Allergy Clin Immunol (2005) 1.05
Innate immunity and antimicrobial defense systems in psoriasis. Clin Dermatol (2007) 1.04
Cellular genomic maps help dissect pathology in human skin disease. J Invest Dermatol (2007) 1.04
MutS homologues hMSH4 and hMSH5: diverse functional implications in humans. Front Biosci (2007) 1.03
Proliferation-differentiation relationships in the expression of heparin-binding epidermal growth factor-related factors and erbB receptors by normal and psoriatic human keratinocytes. Arch Dermatol Res (2003) 1.01
Skin-derived antileucoproteases (SKALPs): characterization of two new elastase inhibitors from psoriatic epidermis. Br J Dermatol (1990) 1.01
A characteristic subset of psoriasis-associated genes is induced by oncostatin-M in reconstituted epidermis. J Invest Dermatol (2006) 1.00
Unique keratinocyte-specific effects of interferon-gamma that protect skin from viruses, identified using transcriptional profiling. Antivir Ther (2003) 0.97
Calgranulin expression in inflammatory dermatoses. J Pathol (1989) 0.95
Lack of evidence for activation of the hedgehog pathway in psoriasis. J Invest Dermatol (2008) 0.94
Insights into gene modulation by therapeutic TNF and IFNgamma antibodies: TNF regulates IFNgamma production by T cells and TNF-regulated genes linked to psoriasis transcriptome. J Invest Dermatol (2007) 0.92
Overexpression of amphiregulin, a major autocrine growth factor for cultured human keratinocytes, in hyperproliferative skin diseases. Am J Dermatopathol (1996) 0.90
Identification of two endogenous neutrophil-activating peptides in psoriatic skin and inflammatory cells: C5ades arg and NAP. Dermatologica (1989) 0.90
Osmotic response element is required for the induction of aldose reductase by tumor necrosis factor-alpha. J Biol Chem (1999) 0.89
Gene expression of enzymes for tryptophan degradation pathway is upregulated in the skin lesions of patients with atopic dermatitis or psoriasis. J Dermatol Sci (2004) 0.88
Genetically programmed differences in epidermal host defense between psoriasis and atopic dermatitis patients. PLoS One (2008) 0.87
Transcriptional responses of human epidermal keratinocytes to Oncostatin-M. Cytokine (2005) 0.87
Galanin-like peptides exert potent vasoactive functions in vivo. J Invest Dermatol (2006) 0.86
Epiregulin, a member of the EGF family, is over-expressed in psoriatic epidermis. J Dermatol Sci (2006) 0.85
Serine proteinase inhibitors in the skin: role in homeostasis and disease. Curr Protein Pept Sci (2005) 0.80
An integrated map of genetic variation from 1,092 human genomes. Nature (2012) 59.82
MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol (2010) 26.41
A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet (2005) 18.98
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89
Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet (2008) 15.94
A comparison of phasing algorithms for trios and unrelated individuals. Am J Hum Genet (2006) 12.45
Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet (2012) 11.09
Family-based association tests for genomewide association scans. Am J Hum Genet (2007) 10.67
Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet (2009) 9.45
The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits. PLoS Genet (2012) 6.15
Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat Genet (2009) 5.93
Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci (2006) 4.98
D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci (2007) 4.93
Pervasive sharing of genetic effects in autoimmune disease. PLoS Genet (2011) 4.42
Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. Am J Hum Genet (2006) 4.22
Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet (2014) 4.13
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet (2012) 4.13
Genetic loci influencing kidney function and chronic kidney disease. Nat Genet (2010) 3.75
Joint modeling of linkage and association: identifying SNPs responsible for a linkage signal. Am J Hum Genet (2005) 3.62
Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. Neuron (2006) 3.58
Extending rare-variant testing strategies: analysis of noncoding sequence and imputed genotypes. Am J Hum Genet (2010) 3.47
Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nat Genet (2011) 3.46
Mechanisms of photoaging and chronological skin aging. Arch Dermatol (2002) 3.43
Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat Genet (2011) 3.40
Gene expression in skin and lymphoblastoid cells: Refined statistical method reveals extensive overlap in cis-eQTL signals. Am J Hum Genet (2010) 3.28
Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet (2013) 3.25
Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis. J Immunol (2008) 3.22
Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21
Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat Genet (2011) 3.18
Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet (2013) 2.92
Synthetic polymer coatings for long-term growth of human embryonic stem cells. Nat Biotechnol (2010) 2.89
FTO genotype is associated with phenotypic variability of body mass index. Nature (2012) 2.77
Genome-wide association analysis identifies three psoriasis susceptibility loci. Nat Genet (2010) 2.76
Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2. Nat Genet (2010) 2.66
Dissecting the genetic complexity of the association between human leukocyte antigens and rheumatoid arthritis. Am J Hum Genet (2002) 2.47
Association analyses identify six new psoriasis susceptibility loci in the Chinese population. Nat Genet (2010) 2.41
Meta-analysis of genome scans of age-related macular degeneration. Hum Mol Genet (2005) 2.34
Polymorphisms of the IL12B and IL23R genes are associated with psoriasis. J Invest Dermatol (2008) 2.20
Re-emergence of striatal cholinergic interneurons in movement disorders. Trends Neurosci (2007) 2.19
Decreased collagen production in chronologically aged skin: roles of age-dependent alteration in fibroblast function and defective mechanical stimulation. Am J Pathol (2006) 2.10
Global gene expression analysis reveals evidence for decreased lipid biosynthesis and increased innate immunity in uninvolved psoriatic skin. J Invest Dermatol (2009) 2.06
Reduced expression of connective tissue growth factor (CTGF/CCN2) mediates collagen loss in chronologically aged human skin. J Invest Dermatol (2009) 1.93
Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. Am J Hum Genet (2002) 1.93
Collagen fragmentation promotes oxidative stress and elevates matrix metalloproteinase-1 in fibroblasts in aged human skin. Am J Pathol (2008) 1.93
Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis. Am J Hum Genet (2012) 1.88
Genome-wide association study of vitamin B6, vitamin B12, folate, and homocysteine blood concentrations. Am J Hum Genet (2009) 1.87
Meta-analysis of genome-wide studies of psoriasis susceptibility reveals linkage to chromosomes 6p21 and 4q28-q31 in Caucasian and Chinese Hans population. J Invest Dermatol (2004) 1.87
Looking older: fibroblast collapse and therapeutic implications. Arch Dermatol (2008) 1.86
A novel BH3 mimetic reveals a mitogen-activated protein kinase-dependent mechanism of melanoma cell death controlled by p53 and reactive oxygen species. Cancer Res (2006) 1.85
BRAF and NRAS mutations in melanoma and melanocytic nevi. Melanoma Res (2006) 1.85
Connective tissue remodeling induced by carbon dioxide laser resurfacing of photodamaged human skin. Arch Dermatol (2004) 1.85
Meta-analysis confirms the LCE3C_LCE3B deletion as a risk factor for psoriasis in several ethnic groups and finds interaction with HLA-Cw6. J Invest Dermatol (2010) 1.82
IL-1F5, -F6, -F8, and -F9: a novel IL-1 family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expression. J Immunol (2011) 1.80
Molecular dissection of psoriasis: integrating genetics and biology. J Invest Dermatol (2009) 1.79
A cross-platform analysis of 14,177 expression quantitative trait loci derived from lymphoblastoid cell lines. Genome Res (2013) 1.72
Matrix-degrading metalloproteinases in photoaging. J Investig Dermatol Symp Proc (2009) 1.72
A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One (2012) 1.72
Heparin-binding EGF-like growth factor promotes epithelial-mesenchymal transition in human keratinocytes. J Invest Dermatol (2012) 1.70
In vivo stimulation of de novo collagen production caused by cross-linked hyaluronic acid dermal filler injections in photodamaged human skin. Arch Dermatol (2007) 1.69
Novel systemic drugs under investigation for the treatment of psoriasis. J Am Acad Dermatol (2012) 1.66